Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1992-12-22
|
pubmed:abstractText |
Two cases of histologically proven primary cerebral malignant lymphoma were examined serially with positron emission tomography (PET) using 11C-methyl-L-methionine (11C Met). Lesions delineated by 11C Met accumulation extended beyond enhancing areas on either X-ray computed tomography (CT) or magnetic resonance imaging. High uptake of 11C Met accurately showed biologically active and residual tumours, at a time when disappearance of a contrast-enhancing lesion on CT seemed to indicate involution. PET provides valuable information on the extent of tumour and assessment of radiotherapy in malignant lymphoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-3940
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
517-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1436463-Aged,
pubmed-meshheading:1436463-Brain Neoplasms,
pubmed-meshheading:1436463-Cranial Irradiation,
pubmed-meshheading:1436463-Female,
pubmed-meshheading:1436463-Follow-Up Studies,
pubmed-meshheading:1436463-Humans,
pubmed-meshheading:1436463-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:1436463-Lymphoma, Large B-Cell, Diffuse,
pubmed-meshheading:1436463-Male,
pubmed-meshheading:1436463-Middle Aged,
pubmed-meshheading:1436463-Radiotherapy Dosage,
pubmed-meshheading:1436463-Tomography, Emission-Computed
|
pubmed:year |
1992
|
pubmed:articleTitle |
Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma.
|
pubmed:affiliation |
Neurosurgical Service, Akita University Hospital, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|